McIntyre Medical Building
Bastien Castagner obtained a Ph.D. in Chemistry at Columbia University in New York in 2004. His postdoctoral years were spent at ETH Zürich from 2005 - 2008. From 2009 - 2014 he was a Group Leader in the Institute of Pharmaceutical Sciences at ETH Zürich. He joined the Department of Pharmacology & Therapeutics at McGill, as Assistant Professor, in August 2014.
Dr. Castagner’s research focuses on the design of small-molecules and natural product analogues as novel drug candidates. He is especially interested in the chemistry and biology of inositol phosphates. His group has also been involved in novel strategies to inactivate the toxins responsible for the pathogenesis of Clostridium difficile (http://youtu.be/r5kS8cDAGR0).